ASM Global’s SAVOR Food Division Announces U.S. Winners of World’s Premier Search Competition for Young Culinary and Hospitality Talent
SAVOR, the culinary division of the world’s leading producer of live-event experiences, ASM Global, has announced Marcus Youn, chef from Knife Pleat, Regina Gutierrez, waiter from The French Laundry and Mitchell Coriell, mixologist from Soho House – Malibu the winners of the American round of the renowned World Young Chef Young Waiter (WYCYW) competition.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230823913776/en/
Judge/Chef Roland Passot (right) evaluates contestant Marcus Youn during the chef competition of Young Chef Young Waiter USA on Aug. 21, 2023, at the CIA at Copia. Youn would go on to win first place in the competition and heads to Monaco to compete in the world finals in November. (Photo: Andreas Zhou/SAVOR)
Now in its 44th year, WYCYW is the premier competition promoting hospitality as a career choice, aimed at finding the world’s most skilled chefs, waiters and waitresses under the age of 28.
All three winners from YCYW USA will go on to compete in the World Young Chef Young Waiter finals on Nov. 23 and 24 at the Lycée Rainier III in Monaco to showcase their abilities to world-class chefs, hospitality experts and mixologists. A total of 21 contestants from nine countries will face off for the chance to win the world title of best chef, waiter and mixologist under the age of 28 as well as a cash prize of $10,000.
The finals of YCYW USA took place on Aug. 21, 2023, at the prestigious The Culinary Institute of America at Copia (CIA) in Napa, California. Each of the 11 talented young hospitality stars at the finals submitted a video entry to YCYW USA, which was then whittled down by a panel of expert judges, including Roland Passot, propriétaire and chief culinary officer; Adam Busby, certified master chef and general manager of CIA in St. Helena; and more.
These industry veterans also led the in-person judging at the CIA at Copia where finalists were assessed on creativity, innovation, attention to detail and technical ability over an exciting one-day live finale. The USA winners were chosen from a pool of finalists who represented some of the country’s finest establishments, including Knife Pleat, The Surf Club, The French Laundry, Bouchon Bistro, Ad Hoc + Addendum and more.
“We are so proud to host the first-ever YCYW USA competition, as giving these young culinary stars a platform to showcase their skills has always been a priority at SAVOR,” said Shaun Beard, SAVOR’s senior vice president of food and beverage. “During the finale event, not only did we witness remarkable talent from all of the contestants, but we were amazed by their composure, camaraderie, willingness to help and genuine appreciation for each other’s crafts in a high-pressure situation. All competitors have bright and successful futures ahead of them, and we can’t wait to see what they have in store for us next.”
WYCYW aims to highlight the remarkable talent of the finest young professionals building their careers in the industry while championing the skill and passion that hospitality professionals bring to their work. For more information, please visit https://youngchefyoungwaiter.com/.
About SAVOR
SAVOR is the culinary division of ASM Global, the world's leading producer of entertainment experiences, which spans five continents and more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibit centers, and performing arts venues. The team at SAVOR provides top-notch experiences at every event, from the food preparation to the beverage offerings, whether for intimate VIP experiences or banquets with over 20,000 guests. Besides great, authentic chef-driven food, the core elements of SAVOR's food vision include partnerships with local growers, producers and community members; a commitment to using antibiotic-free meats and poultry; and dedication to minimizing impact on the environment through robust sustainability, recycling and composting programs. For more information, please visit savorasmglobal.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230823913776/en/
Contact information
Carla Schalman
breakwhitelight (for ASM Global)
carla@breakwhitelight.com
310-827-3169
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
